Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1995-01-04
1997-03-25
Elliott, George C.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
43525421, 4241891, C12P 2102, C12N 119, A61K 3929
Patent
active
056143842
ABSTRACT:
In order to produce hepatitis B virus (HBV) surface proteins in the form of particles with substantially reduced entrapped carbohydrate content, DNA encoding the HBV surface proteins was expressed in a recombinant yeast host which is deficient in its ability to glycosylate proteins. These HBV surface proteins display the antigenie sites genetically encoded by the S domain of the HBV virion envelope open reading frame and contains substantially reduced levels of entrapped carbohydrate when compared with HBsAg particles produced in "wild-type" yeast cells. These particles are useful as a vaccine for both the active and passive treatment or prevention of disease and/or infection caused by HBV or other agents serologically related to HBV.
REFERENCES:
patent: 4707542 (1987-11-01), Friedman et al.
patent: 4803164 (1989-02-01), Hitzeman et al.
patent: 4816564 (1989-03-01), Ellis et al.
patent: 4963483 (1990-10-01), Ellis et al.
patent: 5133961 (1992-07-01), Ellis et al.
patent: 5135854 (1992-08-01), MacKay et al.
Itoh et al.; Biochemical and Biophysical Research Communications, vol. 141, No. 3; pp. 942-948; Dec. 30, 1986.
Peterson et al.; Proceedings of the National Academy of Sciences USA, vol. 74, No. 4; pp. 1530-1534; Apr. 1977.
Kniskern et al.; Hepatology, vol. 8, No. 1; pp. 82-87; 1988.
E. Jacobs, et al., Simultaneous synthesis and assembly of various hepatitis B surface proteins in Saccharomyces cerevisiae, Gene, 80: pp. 279-291 (1989).
Z. A. Janowicz, et al., Simultaneous Expression of the S and L Surface Antigens of Hepatitis B, and Formation of Mixed Particles in the Methylotrophic Yeast, Hansenula polymorpha, Yeast, 7: pp. 431-443 (1991).
M. Johnston & R. W. Davis, Sequences That Regulate the Divergent GAL1-GAL10 Promoter in Saccharomyces cerevisiae, Mol. & Cell. Bio. 4: pp. 1440-1448 (1984).
L. Ballou, et al., A mutation that prevents glucosylation of the lipid-linked oligosaccharide precursor leads to underglycosylation of secreted yeast invertase, Proc. Nat'l. Acad. Sci., USA 83: pp. 3081-3085 (1986).
P. K. Tsai, et al., Carbohydrate Structure of Saccharomyces cerevisiae mnn9 Mannoprotein, J. of Biol. Chem., 259: pp. 3805-3811 (1984).
L. Ballou, et al., Saccharomyces cerevisiae Mutants That Make Mannoproteins with a Truncated Carbohydrate Outer Chain, J. Biol. Chem. 255: pp. 5986-5991 (1980).
P. Hauser, et al., Immunological properties of recombinant HBsAg produced in yeast, Postgraduate Med. Journal, 63: pp. 83-91 (1987).
J. Petre, et al., Development of a hepatitis-B vaccine from transformed yeast cells, Postgraduate Med. Journal, 63: pp. 73-81 (1987).
C. Carty, et al., Galactose-Regulated Expression of Hepatitis B Surface Antigen by a Recombinant Yeast, Biotechnology Lett., 11: pp. 301-306 (1989).
R. W. Ellis, et al., Preparation and Testing of a Recombinant-Derived Hepatitis B Vaccine Consisting of Pre-S2+S Polypeptides, Viral Hep. & Liver Dis., pp. 1079-1086 (1988).
P. J. Kniskern, et al., A Candidate Vaccine for Hepatitis B Containing the Complete Viral Surface Protein, Hepatology, 8: pp. 82-87 (1988).
W. F. Carman et al., Vaccine-induced escape mutant of hepatitis B virus, Medical Science, 336: pp. 325-329 (1990).
D. R. Milich, et al., A Single 10-Residue Pre-S(1) Peptide Can Prime T Cell Help For Antibody Production To Multiple Epitopes Within The Pre-S(1), Pre-S(2), And S Regions of HBsAg, J. of Immunology, 138: pp. 4457-4465 (1987).
P. J. Kniskern, et al., The Application of Molecular Biology to the Development of Novel Vaccines, Immunobio. of Proteins & Peptides V, pp. 83-98 (1989).
P. Valenzuela, Antigen Engineering in Yeast: Synthesis and Assembly of Hybrid Hepatitis B Surface Antigen-Herpes Simplex 1 gD Particles, Biotechnology, 3: pp. 323-326 (1985).
Itoh, et al., Synthesis in Yeast of Hepatitis B Virus Surface Antigen Modified P31 Particles by Gene Modification, Biochem. Biophys. Res. Comm., 141: pp. 942-948 (1986).
Peterson, et al., Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen, Proc. Nat'l. Acad. Sci., 74: pp. 1530-1534 (1977).
Hilleman, Hepatitis B and AIDS and the promise for their control by vaccines, Vaccine, 6: pp. 175-179 (1988).
Hagopian Arpi
Kniskern Peter J.
Elliott George C.
Hand J. Mark
Merck & Co. , Inc.
Tribble Jack L.
LandOfFree
Hepatitis B virus surface proteins with reduced host carbohydrat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis B virus surface proteins with reduced host carbohydrat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis B virus surface proteins with reduced host carbohydrat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2202390